Efficacy of Belatacept in Reducing DSA
NCT02078193
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplantation
Interventions
DRUG:
Belatacept
Sponsor
East Carolina University